Lakewood Capital Management’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
Other funds holding ELV
Lakewood Capital Management's ELV Position: Q2 2026 in Review
Lakewood Capital Management reduced its Elevance Health (ELV) stake by 47% in Q2 2026, selling an estimated $19.7M and leaving 59,350 shares worth $23M. The position accounts for 1.18% of the portfolio, ranked #31.
Lakewood Capital Management first reported a position in ELV in Q4 2019 and has held it in 22 quarters since. The position peaked at $97.5M in Q3 2025. 1,601 funds tracked by Wall St. Rank hold ELV as of Q2 2026.
- Lakewood Capital Management held 59,350 shares of Elevance Health worth $23M as of Q2 2026.
- Lakewood Capital Management sold 53,000 Elevance Health shares in Q2 2026, an estimated $19.7M.
- Elevance Health made up 1.18% of Lakewood Capital Management's portfolio in Q2 2026, its #31 holding.
- Lakewood Capital Management first reported a position in Elevance Health in Q4 2019 and has held it in 22 quarters since.
- Lakewood Capital Management's Elevance Health position peaked at $97.5M in Q3 2025.
- 1,601 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.
Based on Lakewood Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.